InMed Pharmaceuticals Inc

INM

NASDAQ. Currency in USD

7.95 +0.56 ( +7.58% )

Real time prices: October 06

Market Cap.
7.22M
Beta (5Y monthly)
1.51
Price/Earnings
-
EPS (TTM)
-33.17
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
244,313
1y Target Est.
20.00
Day's Range
7.01
-
8.76
52 Week's Range
4.95
-
59.25

Historical Summary

Performance
EPS growth
Share Buybacks

About InMed Pharmaceuticals Inc

Sector
Healthcare
Industry
Biotechnology
Website
https://www.inmedpharma.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
14.14M
Employees
13
Address
815 West Hastings Street, Vancouver, BC, Canada, V6C 1B4
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

Latest news

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session

Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 55.1% to $2.1411 after the company reported results...
By Benzinga - 6 days ago

Wall Street Mixed; Dow Drops Over 50 Points
Wall Street Mixed; Dow Drops Over 50 Points

U.S. stocks traded mixed this morning, with the Dow Jones dropping more than 50 points...
By Benzinga - 6 days ago

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics...
By Benzinga - 1 week ago

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session

Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares surged 159.9% to $9.15. Avenue Therapeutics recently received...
By Benzinga - 1 week ago

US Stocks Open Higher; Dow Surges 300 Points
US Stocks Open Higher; Dow Surges 300 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on...
By Benzinga - 1 week ago

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89...
By Benzinga - 1 week ago

InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update

VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the...
By GlobeNewswire Inc. - 1 week ago